넷타겟 - 넷타겟
KRW 89.50
넷타겟
South Korea-based KAIST spinout startup, NetTargets is developing high-performance drug development platforms on the basis of AI-enhanced systems biology.
넷타겟
South Korea-based KAIST spinout startup, NetTargets is developing high-performance drug development platforms on the basis of AI-enhanced systems biology.